User menu

Prognostic value of short-term decline of forced expiratory volume in 1 s over height cubed (FEV1/Ht(3)) in a cohort of adults aged 80 and over.

Bibliographic reference Hegendörfer, Eralda ; Vaes, Bert ; Matheï, Catharina ; Van Pottelbergh, Gijs ; Degryse, Jean-Marie. Prognostic value of short-term decline of forced expiratory volume in 1 s over height cubed (FEV1/Ht(3)) in a cohort of adults aged 80 and over.. In: Aging Clinical and Experimental Research, Vol. 29, no.4, p. 650-656 (2017)
Permanent URL
  1. Jacobsen Peter K., Sigsgaard Torben, Pedersen Ole F., Christensen Kaare, Miller Martin R., LUNG FUNCTION AS A PREDICTOR OF SURVIVAL IN VERY ELDERLY PEOPLE: THE DANISH 1905 COHORT STUDY : LETTERS TO THE EDITOR, 10.1111/j.1532-5415.2008.01969.x
  2. Singh-Manoux Archana, Dugravot Aline, Kauffmann Francine, Elbaz Alexis, Ankri Joel, Nabi Hermann, Kivimaki Mika, Sabia Séverine, Association of lung function with physical, mental and cognitive function in early old age, 10.1007/s11357-010-9189-x
  3. Lee Hwa Mu, Liu Michael A., Barrett-Connor Elizabeth, Wong Nathan D., Association of lung function with coronary heart disease and cardiovascular disease outcomes in elderly: The Rancho Bernardo study, 10.1016/j.rmed.2014.09.016
  4. Hegendörfer Eralda, Vaes Bert, Andreeva Elena, Matheï Catharina, Van Pottelbergh Gijs, Degryse Jean-Marie, Predictive Value of Different Expressions of Forced Expiratory Volume in 1 Second (FEV1) for Adverse Outcomes in a Cohort of Adults Aged 80 and Older, 10.1016/j.jamda.2016.08.012
  5. Lara Jose, Cooper Rachel, Nissan Jack, Ginty Annie T, Khaw Kay-Tee, Deary Ian J, Lord Janet M, Kuh Diana, Mathers John C, A proposed panel of biomarkers of healthy ageing, 10.1186/s12916-015-0470-9
  6. Bousquet Jean, Dinh-Xuan Anh Tuan, Similowski Thomas, Malva João, Ankri Joël, Barbagallo Mario, Fabbri Leonardo, Humbert Marc, Mercier Jacques, Robalo-Cordeiro Carlos, Rodriguez-Manas Leocadio, Vellas Bruno, Should we use gait speed in COPD, FEV1in frailty and dyspnoea in both?, 10.1183/13993003.00633-2016
  7. Miller Martin R., Does the use of per cent of predicted have any evidence base?, 10.1183/09031936.00199414
  8. Miller M. R., Pedersen O. F., New concepts for expressing forced expiratory volume in 1 s arising from survival analysis, 10.1183/09031936.00025809
  9. Chinn S., Gislason T., Aspelund T., Gudnason V., Optimum expression of adult lung function based on all-cause mortality: Results from the Reykjavik study, 10.1016/j.rmed.2006.06.009
  10. Turkeshi Eralda, Vaes Bert, Andreeva Elena, Matheï Catharina, Adriaensen Wim, Van Pottelbergh Gijs, Degryse Jean-Marie, Short-term prognostic value of forced expiratory volume in 1 second divided by height cubed in a prospective cohort of people 80 years and older, 10.1186/s12877-015-0013-4
  11. Pedone Claudio, Scarlata Simone, Scichilone Nicola, Forastiere Francesco, Bellia Vincenzo, Antonelli-Incalzi Raffaele, Alternative ways of expressing FEV1and mortality in elderly people with and without COPD, 10.1183/09031936.00008812
  13. Sircar K., Hnizdo E., Petsonk E., Attfield M., Decline in lung function and mortality: implications for medical monitoring, 10.1136/oem.2006.031419
  14. Kerstjens H. A., Rijcken B., Schouten J. P., Postma D. S., Decline of FEV1 by age and smoking status: facts, figures, and fallacies, 10.1136/thx.52.9.820
  15. Ryan G., Knuiman M. W., Divitini M. L., James A., Musk A. W., Bartholomew H. C., Decline in lung function and mortality: the Busselton Health Study, 10.1136/jech.53.4.230
  16. Mannino David M., Reichert Matthew M., Davis Kourtney J., Lung Function Decline and Outcomes in an Adult Population, 10.1164/rccm.200508-1344oc
  17. Mannino D M, Lung function decline and outcomes in an elderly population, 10.1136/thx.2005.052449
  18. Tockman M S, Pearson J D, Fleg J L, Metter E J, Kao S Y, Rampal K G, Cruise L J, Fozard J L, Rapid decline in FEV1. A new risk factor for coronary heart disease mortality., 10.1164/ajrccm.151.2.7842197
  19. Abstracts of the 3rd North American Congress of Epidemiology, June 21-24, 2011 Montreal, Canada, 10.1093/aje/kwr181
  20. Vaz Fragoso Carlos A., McAvay Gail, Van Ness Peter H., Metter E. Jeffrey, Ferrucci Luigi, Yaggi H. Klar, Concato John, Gill Thomas M., Aging-Related Considerations When Evaluating the Forced Expiratory Volume in 1 Second (FEV1) Over Time, 10.1093/gerona/glv201
  21. United Nations (2012) Population aging and development. United Nations. . Accessed 21 Jan 2017
  22. Vaes Bert, Pasquet Agnes, Wallemacq Pierre, Rezzoug Nawel, Mekouar Hassan, Olivier Pierre-Alexandre, Legrand Delphine, Matheï Catharina, Van Pottelbergh Gijs, Degryse Jan, The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium, 10.1186/1471-2318-10-39
  23. Quanjer Philip H., Schouten Jan P., Miller Martin R., Ruppel Gregg, Avoiding Bias in the Annualized Rate of Change of FEV1, 10.1164/ajrccm.175.3.291
  24. Nadri Fazlur R., Evaluation of Chronic Cough in a Tertiary Care Center in Tropics, 10.1378/chest.130.2.493
  25. Burrows B, Lebowitz MD, Camilli AE, Knudson RJ (1986) Longitudinal changes in forced expiratory volume in one second in adults. Methodologic considerations and findings in healthy nonsmokers. Am Rev Respir Dis 133:974–980. doi: 10.1164/arrd.1986.133.6.974
  26. Miller M. R., Standardisation of spirometry, 10.1183/09031936.05.00034805
  27. Turkeshi Eralda, Zelenukha Dmitry, Vaes Bert, Andreeva Elena, Frolova Elena, Degryse Jean-Marie, Predictors of poor-quality spirometry in two cohorts of older adults in Russia and Belgium: a cross-sectional study, 10.1038/npjpcrm.2015.48
  28. McWhinnie JR (1981) Disability assessment in population surveys: results of the O.E.C.D. common development effort. Rev Epidemiol Sante Publique 29:413–419
  29. Levey Andrew S., A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation, 10.7326/0003-4819-130-6-199903160-00002
  30. Vaes Bert, Gruson Damien, Van Pottelbergh Gijs, Pasquet Agnes, Matheï Catharina, Adriaensen Wim, Rezzoug Nawel, Vanoverschelde Jean-Louis, Degryse Jan, The impact of confounders on the test performance of natriuretic peptides for cardiac dysfunction in subjects aged 80 and older, 10.1016/j.peptides.2012.08.020
  31. Go Alan S., Chertow Glenn M., Fan Dongjie, McCulloch Charles E., Hsu Chi-yuan, Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization, 10.1056/nejmoa041031
  32. Van Pottelbergh Gijs, Vaes Bert, Jadoul Michel, Matheï Catherina, Wallemacq Pierre, Degryse Jean-Marie, The prevalence and detection of chronic kidney disease (CKD)-related metabolic complications as a function of estimated glomerular filtration rate in the oldest old, 10.1016/j.archger.2011.12.010
  33. Wilber Scott T., Fu Rongwei, Risk Ratios and Odds Ratios for Common Events in Cross-sectional and Cohort Studies : RRs AND ORs FOR COMMON EVENTS IN CROSS-SECTIONAL AND COHORT STUDIES, 10.1111/j.1553-2712.2010.00773.x
  34. GRIFFITH KENT A., SHERRILL DUANE L., SIEGEL ERIN M., MANOLIO TERI A., BONEKAT HORACE W., ENRIGHT PAUL L., Predictors of Loss of Lung Function in the Elderly : The Cardiovascular Health Study, 10.1164/ajrccm.163.1.9906089
  35. Sabia Séverine, Shipley Martin, Elbaz Alexis, Marmot Michael, Kivimaki Mika, Kauffmann Francine, Singh-Manoux Archana, Why Does Lung Function Predict Mortality? Results From the Whitehall II Cohort Study, 10.1093/aje/kwq294
  36. Vaes Bert, De Ruijter Wouter, Degryse Jan, Westendorp Rudi G. J., Gussekloo Jacobijn, Clinical Relevance of a Raised Plasma N-Terminal Pro-Brain Natriuretic Peptide Level in a Population-Based Cohort of Nonagenarians : PLASMA NT-proBNP IN THE VERY ELDERLY, 10.1111/j.1532-5415.2009.02218.x
  37. Miller M. R., Thinggaard M., Christensen K., Pedersen O. F., Sigsgaard T., Best lung function equations for the very elderly selected by survival analysis, 10.1183/09031936.00100313
  38. Stanojevic S., Wade A., Stocks J., Reference values for lung function: past, present and future, 10.1183/09031936.00143209
  39. Fletcher CM PR, Tinker CM et al (1976) The natural history of chronic bronchitis and emphysema. Oxford University Press, Oxford
  40. Fried L. P., Ferrucci L., Darer J., Williamson J. D., Anderson G., Untangling the Concepts of Disability, Frailty, and Comorbidity: Implications for Improved Targeting and Care, 10.1093/gerona/59.3.m255
  41. Pellegrino R., Interpretative strategies for lung function tests, 10.1183/09031936.05.00035205
  42. Hnizdo E., Sircar K., Yan T., Harber P., Fleming J., Glindmeyer H. W, Limits of longitudinal decline for the interpretation of annual changes in FEV1 in individuals, 10.1136/oem.2006.031146